• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环境暴露对人类细胞和癌症的致突变影响:随时间的印记

The Mutagenic Impact of Environmental Exposures in Human Cells and Cancer: Imprints Through Time.

作者信息

Rosendahl Huber Axel, Van Hoeck Arne, Van Boxtel Ruben

机构信息

Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.

Oncode Institute, Utrecht, Netherlands.

出版信息

Front Genet. 2021 Oct 20;12:760039. doi: 10.3389/fgene.2021.760039. eCollection 2021.

DOI:10.3389/fgene.2021.760039
PMID:34745228
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8565797/
Abstract

During life, the DNA of our cells is continuously exposed to external damaging processes. Despite the activity of various repair mechanisms, DNA damage eventually results in the accumulation of mutations in the genomes of our cells. Oncogenic mutations are at the root of carcinogenesis, and carcinogenic agents are often highly mutagenic. Over the past decade, whole genome sequencing data of healthy and tumor tissues have revealed how cells in our body gradually accumulate mutations because of exposure to various mutagenic processes. Dissection of mutation profiles based on the type and context specificities of the altered bases has revealed a variety of signatures that reflect past exposure to environmental mutagens, ranging from chemotherapeutic drugs to genotoxic gut bacteria. In this review, we discuss the latest knowledge on somatic mutation accumulation in human cells, and how environmental mutagenic factors further shape the mutation landscapes of tissues. In addition, not all carcinogenic agents induce mutations, which may point to alternative tumor-promoting mechanisms, such as altered clonal selection dynamics. In short, we provide an overview of how environmental factors induce mutations in the DNA of our healthy cells and how this contributes to carcinogenesis. A better understanding of how environmental mutagens shape the genomes of our cells can help to identify potential preventable causes of cancer.

摘要

在生命过程中,我们细胞中的DNA不断受到外部损伤过程的影响。尽管存在各种修复机制的活动,但DNA损伤最终会导致我们细胞基因组中突变的积累。致癌突变是致癌作用的根源,而致癌剂通常具有高度致突变性。在过去十年中,健康组织和肿瘤组织的全基因组测序数据揭示了我们体内的细胞如何因暴露于各种诱变过程而逐渐积累突变。根据改变碱基的类型和上下文特异性对突变谱进行剖析,揭示了各种反映过去暴露于环境诱变剂的特征,从化疗药物到具有基因毒性的肠道细菌。在这篇综述中,我们讨论了关于人类细胞中体细胞突变积累的最新知识,以及环境诱变因素如何进一步塑造组织的突变格局。此外,并非所有致癌剂都会诱导突变,这可能指向其他肿瘤促进机制,如改变的克隆选择动态。简而言之,我们概述了环境因素如何在我们健康细胞的DNA中诱导突变以及这如何促进致癌作用。更好地理解环境诱变剂如何塑造我们细胞的基因组有助于识别潜在的可预防癌症原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf8/8565797/eadd383da88a/fgene-12-760039-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf8/8565797/a13256e523f0/fgene-12-760039-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf8/8565797/1d40b2297250/fgene-12-760039-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf8/8565797/eadd383da88a/fgene-12-760039-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf8/8565797/a13256e523f0/fgene-12-760039-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf8/8565797/1d40b2297250/fgene-12-760039-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf8/8565797/eadd383da88a/fgene-12-760039-g003.jpg

相似文献

1
The Mutagenic Impact of Environmental Exposures in Human Cells and Cancer: Imprints Through Time.环境暴露对人类细胞和癌症的致突变影响:随时间的印记
Front Genet. 2021 Oct 20;12:760039. doi: 10.3389/fgene.2021.760039. eCollection 2021.
2
Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.秀丽隐杆线虫突变特征分析:对癌症基因组分析的启示。
DNA Repair (Amst). 2020 Nov;95:102957. doi: 10.1016/j.dnarep.2020.102957. Epub 2020 Aug 28.
3
Environmental and chemical carcinogenesis.环境与化学致癌作用
Semin Cancer Biol. 2004 Dec;14(6):473-86. doi: 10.1016/j.semcancer.2004.06.010.
4
Comprehensive investigation of the mutagenic potential of six pesticides classified by IARC as probably carcinogenic to humans.对国际癌症研究机构(IARC)归类为可能对人类致癌的六种农药的致突变潜力进行全面调查。
Chemosphere. 2024 Aug;362:142700. doi: 10.1016/j.chemosphere.2024.142700. Epub 2024 Jun 25.
5
Environmental Carcinogenesis and Transgenerational Transmission of Carcinogenic Risk: From Genetics to Epigenetics.环境致癌作用与致癌风险的跨代传递:从遗传学到表观遗传学。
Int J Environ Res Public Health. 2018 Aug 20;15(8):1791. doi: 10.3390/ijerph15081791.
6
Mutational signatures and mutable motifs in cancer genomes.癌症基因组中的突变特征和可突变基序。
Brief Bioinform. 2018 Nov 27;19(6):1085-1101. doi: 10.1093/bib/bbx049.
7
Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention.致癌物暴露的突变特征:全基因组检测与癌症预防的新机遇。
Genome Med. 2014 Mar 31;6(3):24. doi: 10.1186/gm541. eCollection 2014.
8
Genotoxicity of 1,3-butadiene and its epoxy intermediates.1,3 - 丁二烯及其环氧中间体的遗传毒性。
Res Rep Health Eff Inst. 2009 Aug(144):3-79.
9
The Dynamics of Somatic Mutagenesis During Life in Humans.人类一生中体细胞诱变的动力学
Front Aging. 2021 Dec 17;2:802407. doi: 10.3389/fragi.2021.802407. eCollection 2021.
10
1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.1,3 - 丁二烯:癌症、突变与加合物。第三部分:1,3 - 丁二烯及其代谢产物对小鼠和大鼠内源性次黄嘌呤 - 鸟嘌呤磷酸核糖转移酶(hprt)基因的体内突变作用
Res Rep Health Eff Inst. 2000 Mar(92):89-139; discussion 141-9.

引用本文的文献

1
Genetic landscape of cancer: mechanisms, key genes, and therapeutic implications.癌症的遗传图谱:机制、关键基因及治疗意义。
Clin Transl Oncol. 2025 Aug 17. doi: 10.1007/s12094-025-04019-4.
2
Environmental Hazards and Glial Brain Tumors: Association or Causation?环境危害与胶质脑肿瘤:关联还是因果关系?
Int J Mol Sci. 2025 Aug 1;26(15):7425. doi: 10.3390/ijms26157425.
3
Acute Myeloid Leukaemia and Acute Lymphoblastic Leukaemia Classification and Metabolic Characteristics for Informing and Advancing Treatment.急性髓系白血病和急性淋巴细胞白血病的分类及代谢特征,为治疗提供信息并推动治疗进展

本文引用的文献

1
Somatic mutation rates scale with lifespan across mammals.哺乳动物的体细胞突变率与寿命成正比。
Nature. 2022 Apr;604(7906):517-524. doi: 10.1038/s41586-022-04618-z. Epub 2022 Apr 13.
2
Mutant clones in normal epithelium outcompete and eliminate emerging tumours.正常上皮中的突变克隆会与新出现的肿瘤竞争并消除它们。
Nature. 2021 Oct;598(7881):510-514. doi: 10.1038/s41586-021-03965-7. Epub 2021 Oct 13.
3
Mutation signatures of pediatric acute myeloid leukemia and normal blood progenitors associated with differential patient outcomes.
Cancers (Basel). 2024 Dec 11;16(24):4136. doi: 10.3390/cancers16244136.
4
MADDD-seq, a novel massively parallel sequencing tool for simultaneous detection of DNA damage and mutations.MADDD-seq,一种用于同时检测 DNA 损伤和突变的新型大规模平行测序工具。
Nucleic Acids Res. 2024 Sep 9;52(16):e76. doi: 10.1093/nar/gkae632.
5
Methods and applications of genome-wide profiling of DNA damage and rare mutations.全基因组 DNA 损伤和稀有突变的分析方法与应用。
Nat Rev Genet. 2024 Dec;25(12):846-863. doi: 10.1038/s41576-024-00748-4. Epub 2024 Jun 25.
6
Bacterial immunotherapy: is it a weapon in our arsenal in the fight against cancer?细菌免疫疗法:它是我们对抗癌症的武器库中的一种武器吗?
Front Immunol. 2023 Nov 27;14:1277677. doi: 10.3389/fimmu.2023.1277677. eCollection 2023.
7
Human DNA Mutations and their Impact on Genetic Disorders.人类 DNA 突变及其对遗传疾病的影响。
Recent Pat Biotechnol. 2024;18(4):288-315. doi: 10.2174/0118722083255081231020055309.
8
Risk Factors for Medication-Related Osteonecrosis of the Jaw-A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid.颌骨药物相关性骨坏死的危险因素——对克拉约瓦和康斯坦察接受唑来膦酸治疗的癌症患者数据的二项式分析
J Clin Med. 2023 May 29;12(11):3747. doi: 10.3390/jcm12113747.
9
Standards for Quantitative Measurement of DNA Damage in Mammalian Cells.哺乳动物细胞 DNA 损伤定量测量标准。
Int J Mol Sci. 2023 Mar 12;24(6):5427. doi: 10.3390/ijms24065427.
10
MicroRNAs and Gene Regulatory Networks Related to Cleft Lip and Palate.微小 RNA 与唇腭裂相关的基因调控网络。
Int J Mol Sci. 2023 Feb 10;24(4):3552. doi: 10.3390/ijms24043552.
与患者预后相关的儿童急性髓系白血病和正常血液祖细胞的突变特征。
Blood Cancer Discov. 2021 Sep;2(5):484-499. doi: 10.1158/2643-3230.BCD-21-0010.
4
Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients.抗病毒治疗会在移植受者的癌症中产生独特的突变特征。
Cell Stem Cell. 2021 Oct 7;28(10):1726-1739.e6. doi: 10.1016/j.stem.2021.07.012. Epub 2021 Sep 7.
5
The evolution of hematopoietic cells under cancer therapy.癌症治疗下造血细胞的演变。
Nat Commun. 2021 Aug 10;12(1):4803. doi: 10.1038/s41467-021-24858-3.
6
Mutagenic Consequences of Sublethal Cell Death Signaling.亚致死细胞死亡信号的诱变后果。
Int J Mol Sci. 2021 Jun 7;22(11):6144. doi: 10.3390/ijms22116144.
7
A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage.一项系统性的CRISPR筛选确定了复制错误和内源性DNA损伤所导致的特征背后的突变机制。
Nat Cancer. 2021 Jun;2(6):643-657. doi: 10.1038/s43018-021-00200-0. Epub 2021 Apr 26.
8
Discovery and Features of an Alkylating Signature in Colorectal Cancer.发现并解析结直肠癌中的烷基化特征。
Cancer Discov. 2021 Oct;11(10):2446-2455. doi: 10.1158/2159-8290.CD-20-1656. Epub 2021 Jun 17.
9
Learning mutational signatures and their multidimensional genomic properties with TensorSignatures.使用 TensorSignatures 学习突变特征及其多维基因组特性。
Nat Commun. 2021 Jun 15;12(1):3628. doi: 10.1038/s41467-021-23551-9.
10
Accurate genomic variant detection in single cells with primary template-directed amplification.单细胞中基于初级模板定向扩增的精确基因组变异检测。
Proc Natl Acad Sci U S A. 2021 Jun 15;118(24). doi: 10.1073/pnas.2024176118.